ProQR’s stock jumps on expanded RNA deal with Lilly

Shares of ProQR Therapeutics NV PRQR, +73.03% soared 56.3% in premarket trading on Thursday after the company said it expanded an RNA editing deal with Eli Lilly & Co. Inc. LLY, -1.49% aimed at ma...